Orange, Purple, and the Drugs Between Them

Panelists will discuss hot topics related to Hatch-Waxman and biosimilar litigation, including recent scrutiny from the FTC over what patents may be listed in the Orange Book. 

 

Questions? Inquiries about program materials? Contact Trenon Browne at tbrowne@bostonbar.org